Status:
COMPLETED
Platelet Hyperreactivity Project
Lead Sponsor:
Pierre Fontana
Conditions:
Platelet Reactivity
Eligibility:
All Genders
18-99 years
Brief Summary
The PHP study aims to delineate gene products involved in high on-treatment platelet reactivity in aspirin-treated cardiovascular patients.
Detailed Description
The PHP study aims to delineate gene products involved in high on-treatment platelet reactivity in aspirin-treated cardiovascular patients using a system biology approach that include proteomics analy...
Eligibility Criteria
Inclusion
- Documented symptomatic ischemic atherothrombotic disease treated by aspirin.
Exclusion
- Known platelet disorder
- Chronic treatment by antiplatelet drugs other than aspirin
- Chronic anticoagulant treatment
- Chronic non steroidal anti-inflammatory drug treatment
- Active cancer
- Treatment with serotonin reuptake inhibitors
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00976196
Start Date
January 1 2009
End Date
January 1 2010
Last Update
December 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Geneva
Geneva, Switzerland, 1205